The time to move cytochrome P450 induction into mainstream pharmacology is long overdue

Drug Metabolism and Disposition

Volumn 35, Issue 4, 2007, Pages 697-698

  Smith, Dennis A ^a,c   Dickins, Maurice ^a   Fahmi, Odette A ^b   Iwasaki, Kazuhide ^b   Lee, Caroline ^b   Scott Obach, R ^b   Padbury, Guy ^b   De Morais, Sonia M ^b   Ripp, Sharon L ^b   Stevens, Jeff ^b   Voorman, Richard ^b   Youdim, Kuresh ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Sandwich Laboratories ^*

^c Sandwich Laboratories   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM CHANNEL; CYTOCHROME P450 3A4; ETHINYLESTRADIOL; MIDAZOLAM; NIFEDIPINE; PHENYTOIN; RIFAMPICIN; SODIUM CHANNEL; TROGLITAZONE;

BINDING AFFINITY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; HUMAN; LETTER; LIGAND BINDING; LOW DRUG DOSE; PRIORITY JOURNAL;

EID: 34047146465     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.013284     Document Type: Letter

References (8)

1. Chang TKH and Waxman DJ (2006) Synthetic drugs and natural products as modulators of constitutive androstane receptor and pregnane X receptor. Drug Metab Rev 38:51-73.
2. Lin JH (2006) CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 23:1089-1116.
3. Reschly EJ and Krasowski MD (2006) Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR and CAR) with respect to the metabolism of xenobiotics and endogenous compounds. Curr Drug Metab 7:349-365.
4. Ripp SL, Mills JB, Fahmi OA, Trevena KA, Liras JL, Maurer TS, and de Morais SM (2006) Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug Metab Dispos 34:1742-1748.
5. Ross EM and Kenakin TP (2001) Pharmacodynamics mechanisms of drug action and the relationship between drug concentration and effect, in Goodman and Gilman's The Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) pp 31-43, McGraw-Hill, New York.
6. Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D, Lecluyse EL, and Sinz MW. (2003) Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab Dispos 31:439-446.
7. Sinz M, Kim S, Zhu Z, Chen T, Anthony M, Dickinson K, and Rodrigues AD (2006) Evaluation of 170 xenobiotics as transactivators of Human Pregnane X Receptor (hPXR) and correlation to known CYP3A4 drug interactions. Curr Drug Metab 7:375-388.
8. Smith DA (22000) Induction and drug development. Eur J Pharm Sci 11:185-189.